Centrifuge
Usual
Activity is stable in samples storeed at 4 ºC for up to seven days or four weeks when stored at -20 ºC.
Creatine kinase (CK) is an enzyme that catalyzes the reversible phosphorylation of creatine by adenosine triphosphate (ATP). The CK enzyme is a dimer composed of subunits derived from either muscle (M) or brain (B). Three isoenzymes have been identified: striated muscle (MM), heart tissue (MB), and brain (BB). Normal serum CK is predominantly the CK-MM isoenzyme. Serum CK concentrations are reflective of muscle mass causing males to have higher concentrations than females. CK may be measured to evaluate myopathy and to monitor patients with rhabdomyolysis for acute kidney injury.
None
Creatine Kinase (CK, CPK) is an enzyme found primarily in the heart and skeletal muscles, and to a lesser extent in the brain. Significant injury to any of these structures will lead to a measurable increase in CK levels. Elevations in CK are found in:
Myocardial infarction
Crushing muscular trauma
Any cardiac or muscle disease
Brain injury
Hypothyroidism
Hypokalemia
Malignant hyperthermia
Drugs (statins, fibrates, antiretrovirals etc)
Macro CK
CK can be raised following injury to the myocardium and can be detected 4h after an infarction. Hs troponin I and ECGs are now used routinely to diagnose MI or acute coronary syndrome. Muscle trauma causes CK elevations within 12 hours of onset, peaking within 1 to 3 days, and declining 3 to 5 days after cessation of muscle injury. If there is on-going injury, the CK will remain elevated indefinitely. Serum CK activities exceeding 200 times the upper reference limit may be found in acute rhabdomyolysis, putting the patient at great risk for developing acute renal failure.
Females 29 - 168 U/L
Males 30 - 200 U/L
CK levels are higher in males than in females, and in black race populations. Exercise, muscle trauma (contact sports, traffic accidents, intramuscular injections, surgery, convulsions, wasp or bee stings, and burns), and drugs such as cholesterol-lowering statins can damage muscle and increase serum CK concentrations.
NEQAS
Copyright UHB Pathology 2018
Protection of Personal Information – Clinical Laboratory Services comply with the Trust Data Protection Policy and have procedures in place to allow the Directorate and it’s employees to comply with the Data Protection Act 1998 and associated best practice and guidance.
University Hospitals Birmingham medical laboratories at Queen Elizabeth Hospital, Heartlands Hospital, Good Hope Hospital and Solihull Hospital are UKAS (United Kingdom Accreditation Service) accredited to the ISO 15189:2012 standard. For a list of accredited tests and other information please visit the UKAS website using the following link: https://www.ukas.com/find-an-organisation/
Tests not appearing on the UKAS Schedule of Accreditation currently remain outside of our scope of accreditation. However, these tests have been validated to the same high standard as accredited tests and are performed by the same trained and competent staff.
For further test information, please visit the test database: http://qehbpathology.uk/test-database
For further information contact Louise Fallon, Quality Manager, 0121 371 5962